C. McCormack

发表

Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma.

J. Lewin, G. McArthur, M. Shackleton, 2017 .

Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary Syndrome.

S. Lade, H. Prince, S. Harrison, 2019, Blood.

Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome

C. McCormack, L. Photiou, C. Weyden, 2018, Current Oncology Reports.

Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers

S. Lade, H. Prince, C. McCormack, 2016, The Australasian journal of dermatology.

Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol.

S. Lade, H. Prince, C. McCormack, 2008, Journal of the American Academy of Dermatology.

Management of the primary cutaneous lymphomas

Chris Baker, H. Prince, J. Seymour, 2003, The Australasian journal of dermatology.

The use of methotrexate in dermatology: a review

H. Prince, C. McCormack, S. Shen, 2012, The Australasian journal of dermatology.

Who removes pigmented skin lesions?

R. Marks, D. Jolley, A. Dorevitch, 1997, Journal of the American Academy of Dermatology.

Using an electronic self‐completion tool to identify patients at increased risk of melanoma in Australian primary care

J. Emery, F. Walter, C. McCormack, 2020, The Australasian journal of dermatology.

Diagnosis and Management of Hereditary Basal Cell Skin Cancer.

S. Shanley, C. McCormack, 2016, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions.

M. Henderson, D. Gyorki, D. Speakman, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy.

S. Lade, C. Tam, H. Prince, 2015, Blood.

Successful treatment of Behçet’s disease with lenalidomide

H. Prince, J. Green, C. McCormack, 2007, The British journal of dermatology.

Melanoma in the very elderly, management in patients 85years of age and over.

M. Henderson, D. Gyorki, D. Speakman, 2018, Journal of geriatric oncology.

Retrospective audit of patients referred for further treatment following Mohs surgery for non‐melanoma skin cancer

M. Henderson, W. Murray, P. Tran, 2018, The Australasian journal of dermatology.

Clinical study of primary cutaneous B‐cell lymphoma using both the European Organization for Research and Treatment of Cancer and World Health Organization classifications

H. Prince, J. Seymour, C. McCormack, 2003, The Australasian journal of dermatology.

Lack of Durable Remission with Conventional-Dose Total Skin Electron Therapy for the Management of Sezary Syndrome and Multiply Relapsed Mycosis Fungoides

H. Prince, M. Bressel, C. McCormack, 2019, Cancers.

Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma

P. Atadja, G. Smyth, H. Burris, 2008, Clinical Cancer Research.

Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry (MelCOR): A modified Delphi study

S. Shumack, R. Scolyer, V. Jakrot, 2022, The Australasian journal of dermatology.

Apathy in a sunburnt country: Understanding the skin cancer and sun protection knowledge and practises of Australian doctors

Saxon D. Smith, C. McCormack, P. Dickison, 2018, The Australasian journal of dermatology.

Two cases of acquired perforating dermatosis successfully treated with allopurinol

S. Lade, C. McCormack, M. Goh, 2021, The Australasian journal of dermatology.

Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome

A. Fischer, W. Foulkes, S. Gravel, 2018, Nature Genetics.

Severe treatment-resistant autoimmune haemolytic anaemia following ipilimumab in a patient with metastatic melanoma and CLL

D. Jobson, C. Tam, C. McCormack, 2020, Leukemia & lymphoma.

Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab

H. Prince, C. McCormack, P. Foley, 2009, The Australasian journal of dermatology.

Treatment of primary cutaneous follicular centre lymphoma with rituximab: A report of two cases

H. Prince, G. Kennedy, C. McCormack, 2004, The Australasian journal of dermatology.

Mycosis fungoides and Sézary syndrome: Australian clinical practice statement

S. Lade, H. Prince, J. Shortt, 2020, The Australasian journal of dermatology.

The importance of differentiating between Mycosis Fungoides with CD30 positive large cell transformation and Mycosis Fungoides with co-existent primary cutaneous Anaplastic Large Cell Lymphoma.

S. Lade, H. Prince, C. McCormack, 2020, Journal of the American Academy of Dermatology.

Cutaneous CD30 positive lymphoproliferative disorders with coexistent epithelial neoplasms: Report of two cases

S. Lade, H. Prince, C. McCormack, 2015, The Australasian journal of dermatology.

The efficacy of methotrexate for lymphomatoid papulosis.

S. Lade, H. Prince, M. Dickinson, 2015, Journal of the American Academy of Dermatology.

lymphoma and large cell transformation Long-term outcomes of patients with advanced-stage cutaneous T-cell

S. Lade, H. Prince, C. McCormack, 2013 .

Successful treatment of lymphomatoid papulosis with photodynamic therapy

H. Prince, C. McCormack, Richard A. Williams, 2009, The Australasian journal of dermatology.

Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.

S. Lade, Ashley P Ng, H. Prince, 2006, Haematologica.

Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab

H. Prince, J. Seymour, G. Kennedy, 2003, European journal of haematology.

Methotrexate-induced lymphoproliferative disorder in a patient with Sézary syndrome

S. Lade, H. Prince, C. McCormack, 2006, Leukemia & lymphoma.

Clonal T-helper Lymphocytes and Elevated IL-5 Levels in Episodic Angioedema and Eosinophilia (Gleic h's Syndrome)

I. Glaspole, H. Prince, C. McCormack, 2003, Leukemia & lymphoma.

RESEARCH REPORT Bexarotene capsules and gel for previously treated patients with cutaneous T‐cell lymphoma: Results of the Australian patients treated on phase II trials

H. Prince, C. McCormack, G. Ryan, 2001 .

Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapy

J. Trapani, H. Prince, J. Seymour, 2005, The British journal of dermatology.

Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation

H. Prince, C. McCormack, G. Ryan, 2004, Bone Marrow Transplantation.

Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: results of the Australian patients treated on phase II trials.

H. Prince, C. McCormack, G. Ryan, 2001, The Australasian journal of dermatology.

Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open‐label pilot study in five patients

P. Foley, H. Prince, C. McCormack, 2007, The British journal of dermatology.

Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes.

A. Dorevitch, J. Kelly, C. McCormack, 1997, Archives of dermatology.

Outcomes following management of squamous cell carcinoma of the scalp: A retrospective series of 235 patients treated at the Peter MacCallum Cancer Centre

M. Bressel, J. Spillane, V. Estall, 2017, The Australasian journal of dermatology.

Atypical Spitzoid neoplasms: a review of potential markers of biological behavior including sentinel node biopsy

John Kirkwood, Nick Wong, Richard A Scolyer, 2014, Melanoma research.

Localised pityriasis rosea‐like eruption during radiotherapy. Report of 2 cases

C. Mitchell, C. McCormack, M. Goh, 2015, The Australasian journal of dermatology.

Trends in the incidence of Merkel cell carcinoma in Victoria, Australia, between 1986 and 2016

Saxon D. Smith, C. McCormack, Kieran B Garbutcheon-Singh, 2020, The Australasian journal of dermatology.

Analysis of dermatologic events in vemurafenib-treated patients with melanoma.

A. Hauschild, D. Schadendorf, M. Lacouture, 2013, The oncologist.

Cutaneous leiomyosarcoma: dermal and subcutaneous

M. Henderson, D. Gyorki, S. Ngan, 2020, The Australasian journal of dermatology.

Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma

Gordon K Smyth, Joachim Beck, Ricky W Johnstone, 2008, Clinical Cancer Research.

Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation.

S. Lade, H. Prince, C. McCormack, 2008, Blood.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

J. Scarisbrick, A. Pileri, M. Maule, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

IgA nephropathy associated with cutaneous T cell lymphoma

S. Lade, H. Prince, C. McCormack, 2009, Leukemia & lymphoma.

A systematic review on the management of pruritus in patients with cutaneous T-cell lymphoma

S. Lazarakis, C. McCormack, O. Buelens, 2021 .

Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases.

H. Prince, S. Hall, C. McCormack, 2007, Journal of the American Academy of Dermatology.

Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient

O. Prall, C. McCormack, M. Goh, 2019, Clinical case reports.

Bullous pemphigoid associated with anti‐programmed cell death protein 1 and anti‐programmed cell death ligand 1 therapy: A case series of 13 patients

C. McCormack, M. Goh, Jenny S W Yun, 2022, The Australasian journal of dermatology.

Rare T-Cell Subtypes.

S. Lade, R. Johnstone, H. Prince, 2018, Cancer treatment and research.

CD30‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre

S. Lade, H. Prince, C. McCormack, 2023, The Australasian journal of dermatology.

Accuracy of partial biopsies in the management of cutaneous melanoma

A. Robinson, R. Wolfe, M. Henderson, 2019, The Australasian journal of dermatology.

Primary cutaneous B‐cell lymphomas

H. Prince, C. McCormack, R. Blum, 2003, Clinical and experimental dermatology.

Severe and prolonged myeloid haematopoietic toxicity with myelodysplastic features following alemtuzumab therapy in patients with peripheral T‐cell lymphoproliferative disorders

J. Seymour, C. McCormack, H. Miles Prince, 2005, British journal of haematology.

Alemtuzumab: effective monotherapy for simultaneous B‐cell chronic lymphocytic leukaemia and Sézary syndrome

H. Prince, J. Seymour, S. Gibbs, 2004, European journal of haematology.

Impact of chronic lymphocytic leukaemia on melanoma outcomes: A retrospective case‐control study

C. Tam, M. Henderson, V. Mar, 2022, British journal of haematology.

Eruptive disseminated Spitz naevus (EDSN) in a young girl of Indian origin

R. Scolyer, J. Lee, C. McCormack, 2015, The Australasian journal of dermatology.

Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study

D. Kipp, A. Bazargan, H. Prince, 2020, Leukemia & lymphoma.

Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma

J. Scarisbrick, H. Prince, Youn H. Kim, 2020, Cancers.

Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC‐CLTG/ISCL survey

E. Guenova, R. Knobler, P. Quaglino, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small/ medium T-Cell lymphoproliferative disorder.

S. Lade, C. McCormack, C. van der Weyden, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

S. Lade, H. Prince, C. Cheah, 2014, The Australasian journal of dermatology.

CUTANEOUS LYMPHOMAS: WHICH PATHOLOGICAL CLASSIFICATION?

Chris Baker, H. Prince, C. McCormack, 2002, Pathology.

Patients’ Experiences of Using Skin Self-monitoring Apps With People at Higher Risk of Melanoma: Qualitative Study

J. Emery, F. Walter, C. McCormack, 2021, JMIR Dermatology.

Patients’ Experiences of Using Skin Self-monitoring Apps With People at Higher Risk of Melanoma: Qualitative Study

J. Emery, F. Walter, C. McCormack, 2020, JMIR dermatology.

Efficacy and safety of chaperonin 10 in patients with moderate to severe plaque psoriasis: evidence of utility beyond a single indication.

E. Latz, P. Foley, S. Hall, 2008, Archives of dermatology.

Haber's Syndrome

P. Cowen, C. McCormack, 1997, Australasian Journal of Dermatology.

Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome

A. Fischer, W. Foulkes, S. Gravel, 2018, Nature Genetics.

Unifocal cutaneous blastic plasmacytoid dendritic cell neoplasm with a favorable response following high-dose radiotherapy alone

S. Lade, H. Prince, C. McCormack, 2022, Leukemia & lymphoma.

Hyperlipidaemia presenting as palmoplantar pain

C. McCormack, E. Anthony, Benny J Lichtblau, 2018, The Australasian journal of dermatology.

Scalp BCC's and meningioma following X‐ray epilation for tinea capitis

C. McCormack, M. Goh, L. Anderson, 2018, The Australasian journal of dermatology.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

J. Scarisbrick, A. Pileri, R. Willemze, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

The acceleration of melanoma in situ: A population-based study of melanoma incidence trends from Victoria, Australia, 1985-2015.

V. Harris, Saxon D. Smith, C. McCormack, 2019, Journal of the American Academy of Dermatology.

Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report

C. McCormack, L. Scardamaglia, Chin-Guan Tan, 2022, The Australasian journal of dermatology.

Exacerbation of lymphomatoid papulosis during rituximab therapy

H. Prince, D. Ritchie, C. McCormack, 2014, The Australasian journal of dermatology.

Long‐term clearance of patch‐stage mycosis fungoides with the 308‐nm laser

P. Foley, H. Prince, C. McCormack, 2007, Clincal and Experimental Dermatology.

Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers

S. Lade, C. McCormack, Kate M Newland, 2015 .

Primary cutaneous anaplastic large cell lymphoma and evolving clinical practice: 26 years of skin lesions with locoregional progression to systemic disease

H. Prince, C. McCormack, Crystal Gao, 2020, Leukemia & lymphoma.

Definitive radiotherapy for Merkel cell carcinoma in the setting of epidermolysis bullosa simplex

Lachlan McDowell, C. McCormack, W. Ong, 2018, Australasian Journal of Dermatology.

Sweet syndrome associated with ipilimumab in a patient with metastatic melanoma

W. Murray, C. McCormack, B. Brady, 2018, Clinical and experimental dermatology.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

J. Scarisbrick, A. Pileri, R. Willemze, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies

J. Scarisbrick, H. Prince, M. Bagot, 2023, Blood advances.

LBH589, a Novel Deacetylase Inhibitor (DACi), Treatment of Patients with Cutaneous T-Cell Lymphoma (CTCL). Skin Gene Expression Profiles in the First 24 Hours Related to Clinical Response Following Therapy.

P. Atadja, L. Ellis, R. Johnstone, 2006 .